About/Team
Our Approach
Our leadership team is comprised of passionate experts in product development,
regulatory, clinical, quality, and commercial strategy who bring decades of medical
device and cardiovascular experience and a track record of success in developing life-changing healthcare solutions.
We lead with a thoughtful, yet fearless approach to reimagining a world in which ADHF
patients and those who care for them can achieve better outcomes.
Reprieve Cardiovascular, Inc. develops innovative and groundbreaking therapies that aim to improve the lives of more than 25 million heart failure patients around the world. Reprieve is bringing intelligence to decongestion management to safely accelerate fluid removal for heart failure patients.
Leadership Team
Mark Pacyna
Chief Executive Officer
Tony Fields
Chief Operating Officer
Adam Bartnik
Chief Financial Officer
Andrew Halpert
Vice President of R&D
Annemarie Forrest
Vice President of Clinical Affairs
Cassie Morris
Vice President of Strategy and Innovation
Geoff Cherucheril
Sr. Director of Marketing
Julien Espenon
Director, Europe
Laura Rudeen
Director of Clinical Affairs
Kenneth Luppi
Director of Operations
Jacob Davis
Director of Quality
Don Hefner
Field Clinical Director
Board of Directors
Scientific Advisory Board
Dr. Javed Butler
Dr. Sean Collins
Dr. Michael Jaff
Dr. Julia Lewis
Dr. Jeff Testani
Dr. Jim Udelson